NYSE:HSP - Hospira Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
Previous Close$89.96
Today's RangeN/A
52-Week RangeN/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Hospira, Inc. provides injectable pharmaceutical drugs and infusion technologies and it develops, manufactures, distributes and markets biosimilars. The Company's portfolio includes generic acute-care and oncology injectables, biosimilars, and integrated infusion therapy and medication management products. The Company conducts operations across the world and is managed in three segments: the Americas, which include the United States, Canada, and Latin America; Europe, Middle East, and Africa (EMEA), and the Asia Pacific, which includes Asia, Japan, Australia and New Zealand. Its portfolio of products includes Specialty Injectable Pharmaceuticals, which includes generic injectables, injectables and biosimilars, Medication Management and Other Pharmaceuticals. Its portfolio of products is used by hospitals and alternate site providers, such as clinics, home healthcare providers and long-term care facilities.

Receive HSP News and Ratings via Email

Sign-up to receive the latest news and ratings for HSP and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryPharmaceuticals
SectorN/A
CUSIP44106010
Phone+1-847-9376472

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Hospira (NYSE:HSP) Frequently Asked Questions

What is Hospira's stock symbol?

Hospira trades on the New York Stock Exchange (NYSE) under the ticker symbol "HSP."

How were Hospira's earnings last quarter?

Hospira, Inc. (NYSE:HSP) issued its quarterly earnings data on Wednesday, July, 29th. The healthcare company reported $0.85 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.78 by $0.07. The healthcare company had revenue of $1.20 billion for the quarter, compared to analysts' expectations of $1.18 billion. The business's revenue for the quarter was up 4.2% compared to the same quarter last year. During the same period in the previous year, the business posted $0.72 EPS. View Hospira's Earnings History.

Has Hospira been receiving favorable news coverage?

Media stories about HSP stock have trended somewhat positive this week, according to InfoTrie. The research firm identifies positive and negative media coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Hospira earned a news impact score of 1.7 on InfoTrie's scale. They also gave news coverage about the healthcare company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an effect on the stock's share price in the near term.

How do I buy shares of Hospira?

Shares of HSP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Hospira's official website?

The official website for Hospira is http://www.hospira.com/.

How can I contact Hospira?

Hospira's mailing address is 275 N Field Dr, LAKE FOREST, IL 60045-2579, United States. The healthcare company can be reached via phone at +1-847-9376472.


MarketBeat Community Rating for Hospira (NYSE HSP)

Community Ranking:  1.8 out of 5 (star)
Outperform Votes:  141 (Vote Outperform)
Underperform Votes:  243 (Vote Underperform)
Total Votes:  384
MarketBeat's community ratings are surveys of what our community members think about Hospira and other stocks. Vote "Outperform" if you believe HSP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HSP will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/23/2019 by MarketBeat.com Staff

Featured Article: Risk Tolerance

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel